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Abstract.  An intrinsic membrane protein of brain syn- 
aptic vesicles with Mr 38,000  (p38,  synaptophysin) has 
recently been partially characterized (Jahn, R., W. 
Schiebler, C. Ouimet,  and P.  Greengard,  1985,  Proc. 
Natl.  Acad.  Sci.  USA,  83:4137--4141; Wiedenmann, B., 
and W.  W.  Franke,  1985,  Cell, 41:1017-1028).  We have 
now studied the presence of p38  in a  variety of tissues 
by light and electron microscopy immunocytochemis- 
try and by immunochemistry. Our results indicate that, 
within the nervous system, p38,  like the neuron- 
specific phosphoprotein synapsin I, is present in virtu- 
ally all nerve terminals and is selectively associated 
with small synaptic vesicles (SSVs).  No p38 was de- 
tectable on large dense-core vesicles (LDCVs). p38 
and synapsin I  were found to be present in similar 
concentrations throughout the brain.  Outside the ner- 
vous system, p38 was found in a  variety of neuroendo- 
crine cells, but not in any other cell type. In neu- 
roendocrine cells p38 was localized on a pleiomorphic 
population of small, smooth-surfaced vesicles, which 
were interspersed among secretory granules and con- 
centrated in the Golgi area, but not on the secretory 
granules themselves. Immunoblot analysis of endo- 
crine tissues and cell lines revealed a band with a  mo- 
bility slightly different from that of neuronal p38.  This 
difference was attributable to a difference in glycosy- 
lation. 
The finding that p38,  like synapsin I, is a  compo- 
nent of SSVs of virtually all neurons, but not of 
LDCVs, supports the idea that SSVs and LDCVs are 
organelles of two distinct pathways for regulated neu- 
ronal secretion. In addition, our results indicate the 
presence in a variety of neuroendocrine cells of an en- 
domembrane system, which is related to SSVs of neu- 
rons but is distinct from secretory granules. 
EGULATED vesicular  secretion  of  neurotransmitter 
molecules from nerve endings and regulated vesicu- 
lar secretion from non-neuronal cells have a number 
of features  in  common  (23,  31). However,  nerve  ending 
secretion also shows some specific features.  At least two 
types  of  secretory  organelles,  small  synaptic  vesicles 
(SSVs) 1 and large dense-core vesicles (LDCVs),  coexist in 
some and possibly all nerve endings, where they appear to 
be involved in two distinct secretory pathways (24, 27, 32, 
38).  SSVs (40-60-nm diam) appear to be storage sites for 
only classical neurotransmitters, i.e., small non-peptide mole- 
cules (27). These vesicles undergo a local exo-endocytotic 
recycling in  nerve  terminals.  At  each  cycle they can  be 
reloaded  with  neurotransmitter  because  the  machinery 
necessary to synthesize and load classical neurotransmitters 
1. Abbre~ations used in this paper: control-IgGs, nonimmune rabbit IgGs; 
p38-IgGs, affinity-purified  rabbit serum antibodies directed against p38; syn 
I-IgGs, affinity-purified rabbit serum antibodies directed against synapsin 
I; LDCVs, large dense-core vesicles; SSVs, small synaptic vesicles. 
into vesicles is present in the axon terminal and a direct in- 
volvement of the cell body is not required (6, 38).  SSVs are 
regarded as neuron-specific organelles with no equivalent in 
non-neuronal cells  (32).  In contrast,  LDCVs,  i.e.,  larger 
vesicles (>60-nm diam) with an electron-dense core, appear 
to be storage sites for peptide neurotransmitters (24, 27). The 
nerve terminal is dependent upon a constant supply of preas- 
sembled LDCVs  from the perikaryon, since peptide neu- 
rotransmitters, or their pro-peptide precursors, can only be 
synthesized and loaded into vesicles in perikarya. LDCVs 
can be considered equivalent to secretory granules of endo- 
crine cells, which they resemble in morphology, content, and 
mechanism of assembly (32). 
Some recent studies have suggested that the release from 
SSVs and LDCVs may be, at least partially, independently 
regulated (1,  27).  Furthermore, it has been found that the 
phosphoprotein synapsin I (8-10, 20, 41, 44) is preferential- 
ly, and perhaps exclusively, associated with the surface of 
SSVs (32).  Synapsin I  is a  neuron-specific protein that is 
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where it is tightly bound to the cytoplasmic surface of the 
vesicles (10, 20). 
To further understand the structural and functional rela- 
tionship between  SSVs and LDCVs,  and the  relationship 
between these vesicles and the secretory vesicles of non- 
neuronal cells, it is important to characterize and compare 
the molecular characteristics of intrinsic membrane compo- 
nents of SSVs and LDCVs.  Recently we have characterized 
an intrinsic membrane protein of Mr 38,000 (p38) present in 
a highly purified synaptic vesicle fraction (22).  This protein 
is probably identical to a  protein with the same apparent 
molecular weight identified in brain coated vesicles (36, 49) 
and in presynaptic vesicles (47, referred to as synaptophysin 
in that study). It is an acidic glycoprotein, with a large cyto- 
plasmic domain, which appears to have a widespread distri- 
bution at synapses (22,  37, 47). 
In the present study we have investigated the distribution 
and subcellular localization of p38 in a variety of tissues. We 
report that p38, like synapsin I, is present in all nerve end- 
ings, where it is selectively localized in the membranes of 
SSVs, with little or none being present in the membranes of 
LDCVs. We show further that p38, at variance with synapsin 
I, has a widespread distribution in a variety of neuroendo- 
crine cells, and that in these cells p38 is localized on small 
pleiomorphic vesicles with clear content, but not on secre- 
tory granules. Preliminary accounts of this work have been 
presented previously (33). 
Materials and Methods 
Antibodies 
Monoclonal antibodies (IgG clones C 7.2 and C 7.3) and rabbit serum anti- 
bodies against p38 were generated as described previously (22).  Mono- 
clonal antibodies were purified from ascites fluid using the method of Bruck 
et al. (4).  Serum antibodies directed against p38 (p38-IgGs) were affinity 
purified using a denatured membrane fraction from rat brain as immunoad- 
sorbent by the following procedure. (All steps were carded out at 4°C). 
Starting with 15 rat brains, a P2-fraction was prepared as described (20). 
The P2 pellet was resuspended in  15 ml of 0.1  M  glycine/HCl pH 2.4, 
homogenized vigorously using a glass-Teflon homogenizer, and further dis- 
persed by squeezing it through a 30-gauge needle. After 20 min of stirring, 
the sample was centrifuged at 5,000 g for 15 min. The pellet was washed 
three times in phosphate-buffered saline (PBS; 150 mM NaCl, l0 mM Na- 
phosphate, pH 7.2), resuspended in 10 ml of  anti-p38 serum, and vigorously 
homogenized. After incubation under rotation for 2 h, the mixture was cen- 
trifuged at 15,000 g for 15 min and the pellet was washed five times with 
PBS.  The final pellet was resuspended as above in  10 ml of 0.1  M  gly- 
cine/HCl, pH 2.4 and the mixture incubated for 30 min under rotation to 
allow dissociation of the antibody. The solubilized antibody was recovered 
by centrifugation at 15,000 g for 15 rain. The pellet was re-extracted once 
by the same procedure. The combined supernatants were immediately neu- 
tralized with 1 M Tris-base, dialyzed against PBS, and concentrated using 
an Amicon ultrafiltration apparatus (Amicon Corp., Danvers, MA). This 
is the fraction referred to as "p38-IgGs7 Electrophoretic analysis revealed 
mostly IgG and some IgM, with no detectable contaminants. A typical yield 
was 0.8 mg of protein. 
Both monoclonal and polyclonal antibodies recognized almost exclusive- 
ly one band of Mr "38,000 when tested by immunoblot analysis against 
proteins of total homogenates of rat and bovine tissues, which had been 
separated by SDS gels under reducing conditions (22; see also Fig. 9, top). 
In addition to this band, only a small immunoreactive band of Mr 76,000 
was sometime seen (Fig. 9, top). This corresponded to a dimeric form of 
p38.  Most epitopes recognized by  these antibodies are  located  on the 
cytoplasmic portion of the molecule (22). 
Affinity-purified rabbit polyclonal IgGs directed against synapsin I (syn 
I-IgGs) were prepared and characterized as previously described (8,  10). 
Affinity-purified antibodies directed against secretogranin II (40)  were a 
kind girl ofA. Zanini (Milano). Nonimmune rabbit IgGs (control IgGs) and 
rhodamine-conjugated goat anti-rabbit IgGs were from Cooper Biochemi- 
cal, Inc. (Malvern, PA). 
Purification of  p38 
p38 to be used as a standard for quantitative immunoassay was purified by 
affinity chromatography after detergent extraction of a rat brain membrane 
fraction. 15 male Sprague-Dawley rats (200-250 g) were killed by decapita- 
tion. The forebrains were quickly removed, fired from blood vessels, and 
homogenized in  150 ml of 0.32  M  ice-cold sucrose containing 0.1  mM 
phenylmethylsulfonyl fluoride (PMSF;  Sigma Chemical Co.,  St.  Louis, 
MO) and 2  ~tg/ml pepstatin (Chemicon, E1 Segundo, CA) using a glass- 
Teflon homogenizer. The homogenate was centrifuged at 800 g for 10 rain. 
The resulting low-speed supernatant was spun at 100,000 g for 90 min. The 
resulting high-speed pellet was homogenized in 100 ml of 150 mM NaC1, 
10 mM Na-phosphate pH 7.2,  0.1 mM PMSE and 2 ~tg/ml pepstatin con- 
mining 1% (vol/vol) Triton X-100. After stirring on ice for 60 min, the ex- 
tract was spun again for 90 rain at 100,000 g. The resulting supernatant (Tri- 
ton extract) was used for affinity chromatography. Occasionally the pellet 
(Triton pellet) was re-extracted once, providing a somewhat higher yield. 
An affinity resin was prepared by coupling 25 mg of a mixture of purified 
monoclonal antibodies C'/.2 and C7.3 to 3.5 ml of CNBr-activated Sepha- 
rose-4B (Pharmacia, Uppsala, Sweden) according to the manufacturer's in- 
structions. The Triton extract was loaded, and the column was washed with 
10 ml of PBS containing 1% (vol/vol) Triton X-100, followed by 10 washes 
using alternatively 10 ml of high pH buffer (0.1 M NaHCO3, 0.5 M NaCI 
pH 8.3, 0.1% [vol/vol] Triton X-100) and 10 ml of low pH buffer (0.1 M Na- 
acetate pH 5.5, 0.5 M NaC1, 0.1% [vol/vol] Triton X-100). The column was 
finally washed with 10 ml of PBS containing 0.1% (vol/vol) Triton X-100 and 
eluted with 20 rnl of 3.5 M NaSCN containing 0.1% (vol/vol) Triton X-100. 
The eluate was dialyzed extensively against PBS and finally concentrated 
to 2-3 ml using an Amicon ultrafiltration apparatus. The final product did 
not contain any significant contaminant as judged by SDS PAGE. p38 was 
purified 313-fold over the homogenate, with virtually all of the purification 
being achieved by the affinity chromatography step. p38 was enriched from 
PC12 homogenate (kindly provided to us by Dr. R. Nichols, the Rockefeller 
University) using the same procedure as used for the brain protein. 
Light Microscopy Immunocytochemistry 
Preparation of 1Issue Sections.  Sprague Dawley albino rats,  175-250  g, 
were anesthetized and fixed by transcardial perfusion as described (8). The 
fixative used was 4% formaldehyde (freshly prepared from paraformalde- 
hyde) or 3% formaldehyde/0.25 % glutaraldehyde. At the end of the perfu- 
sion,  brains and other tissues of interest were removed, cut into small 
blocks, and immersed in the same fixative for an additional 3 h. After a rinse 
in PBS (several hours), some blocks were dehydrated in graded ethanols and 
propylene oxide and embedded in Epon for plastic sectioning. Other blocks 
were infiltrated with either 0.5 or 2.3 M sucrose and subsequently frozen 
in isopentane chilled with liquid nitrogen. Tissue infiltrated with the lower 
sucrose concentration was cut in a Reichert-Jung (Vienna, Austria) cryostat 
(10-gm  thick  frozen  sections),  the  other  tissue  in  a  Reichert-Jung 
FC4/Ultracut (1-gm thick frozen sections). Preparation of 1-gm thick plas- 
tic sections and plastic removal were performed as described (8). 
lmmunostaining  and Photography. Immunostaining of sections was 
performed by an indirect immuno-rhodamine procedure as described (8), 
with the exception that affinity-purified serum antibodies rather than whole 
sera were used in the primary labeling step. In all cases antibodies were used 
at the final concentration of 0.1 mg/ml. At the end of the immunostaining, 
glass slides were mounted with 95 % (vol/vol) glycerol in 120 mM sodium 
phosphate buffer and observed with a Zeiss photomicroscope III equipped 
with epifluorescence and planapo objectives. Pictures were taken with tech- 
nical pan 2415 film, which was developed with undiluted D  19. Films and 
chemicals were from Kodak. 
Electron Microscopy Immunocytochemistry 
Agarose-embedded Subcellular Particles. Fresh bovine brains and adrenals 
were obtained from the Milano public slaughterhouse. Within 15-20 min 
from the time of death, brains and adrenal glands were removed from the 
animals,  and  the  tissues  of interest were  dissected out.  Tissues  were 
homogenized  by several manual strokes in 6 vol of  ice cold 0.25 M sucrose/5 
mM sodium phosphate buffer in a glass-Teflon homogenizer. The hypotha- 
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separately. One aliquot was fixed by addition of 1 vol of twofold concen- 
trated fixative in 0.25 M sucrose/5 mM sodium phosphate buffer (nonlytic 
fixation). The other aliquot was fixed by addition of a large amount (more 
than 15 vol) of  onefold concentrated fixative in 5 mM phosphate buffer (lytic 
fixation). For a discussion of lytic versus nonlytic fixation, see reference 10 
and Results. The homogenate of the adrenal medulla was fixed by addition 
of 1 vol of twofold concentrated fixative in 0.25 M  sucrose/5 mM sodium 
phosphate buffer.  In all  cases the final  fixative was  3%  formaldehyde 
(freshly prepared from paraformaldehyde)/0.25% glutaraldehyde. 
After a 30-min fixation on ice, subcellular particles of the homogenate 
were pelleted by centrifugation (13,000 g for 45 min). The compact pellet 
was scraped with a spatula from the bottom of the tube, resuspended in a 
small volume of 120 mM sodium phosphate buffer, and gently rehomog- 
enized in a small glass-Teflon homogenizer. The thick suspension obtained 
was mixed with warm liquid agarose to prepare blocks of agarose-embedded 
particles (10). Immunostaining of agarose blocks was performed as de- 
scribed, using afffinity-purified antibodies at the first labeling step and pro- 
tein A-colloidal gold at the second labeling step. Preparation of gold sols 
and their conjugation to protein A was carried out according to Slot and 
Geuze (42).  After the second labeling step, agarose blocks were further 
fixed with  1%  glutaraldehyde in 120 mM sodium phosphate buffer, then 
postfixed in  1% OsO4,  dehydrated, and embedded in Epon as described 
(10). Thin sections were prepared with an Ultracut Microtome (Reichert- 
Jung) and examined in Phillips 301 and 400 electron microscopes. 
Ultra-thin Frozen Sections.  Preparation and immunolabeling of ultra- 
thin frozen sections of rat anterior pituitary were performed essentially as 
described (18). Briefly, the tissue was fixed by perfusion as for light micros- 
copy immunohistoehemistry,  but using 4% formaldehyde/0.05 % glutaralde- 
hyde as the fixative.  Before sectioning in a  Reichert-Jang FC4/Ultracut, 
small tissue blocks were infiltrated in 2.3 M  sucrose and frozen in liquid 
nitrogen. Immunolabeling was performed as described (18) with the excep- 
tion that (a) step 4 was preceded by a 20-min incubation in a solution con- 
mining 15 % fetal calf serum/0.45 M NaCI/O.02 M sodium phosphate buffer 
(buffer A),  (b) IgGs (final dilution 0.1  mg/ml) and protein A-gold were 
diluted in buffer A, and (c) after step 7, grids were floated on a 2% solution 
of glutaraldehyde in PBS and then rinsed by floating them on PBS alone. 
Contrasting and plastic embedding of  the labeled grids were then performed 
by processing them through the following steps: (a) rinse with 0.1 M acetate- 
veronal (AV) buffer pH 7.4  (twice for 2  min each); (b) postfix with 1% 
OsO4  in AV buffer (15  min);  (c) rinse with AV buffer (twice for 2  min 
each); (d) counterstain with 0.5% uranyl acetate in AV buffer, pH 6.5 (15 
min); (e) wash with distilled water (three times for 2 min each). All these 
steps were performed by floating the grids on a drop of solution. Grids were 
subsequently dehydrated and plastic embedded by transferring them first 
through a series of tubes containing ethanol solutions of increasing concen- 
trations (from 50 to 100%), and then through a series of three tubes contain- 
ing a solution of LR white. Excess LR white was then removed by sandwich- 
ing grids between two small layers of hard Whatman No. 50 (Maidstone, 
England) filter paper which were gently pressed against each other. Finally 
grids were left in a 60°C oven overnight to allow the embedding resin to 
polymerize. 
Other Techniques 
Quantitation of synapsin I and p38  in total homogenates was performed 
using a dot-immunobinding assay (21). p38 prepared from rat brain and 
from PC12 cells as described above was chemically deglycosylated by tri- 
fluoromethanesulfonic acid using the method of Edge et al. (14) as modified 
by J. David Castle (Yale University) and published by Bartles et al. (2). SDS 
PAGE was carried out according to Laemmli (25) using a slab gel apparatus 
(Hoefer Scientific Instruments, San Francisco, CA) and 9-13% linear gra- 
dient gels 1.5-mm thick. Blotting was performed according to Towbin et al. 
(43). Immunostain of the blots by a peroxidase procedure was performed 
as described (22).  Protein was determined by a  modification (28) of the 
method of Lowry et al. (26). Primary cultures of bovine adrenal chromaffin 
cells were a kind gift of R. A. Nichols and J.  Haycock (The Rockefeller 
University). 
Results 
Distribution  of  p38 in the Nervous System and 
Comparison with the Distribution  of Synapsin I 
Immunofluorescence  staining  of frozen (10-1xm thick)  and 
plastic (1-1xm thick) sections of a variety of brain areas with 
p38-IgGs produced a punctate pattern of staining in all nerve 
terminal-containing regions, leaving all regions of the white 
matter unstained. The morphological distribution of p38 was 
very similar to that of synapsin I  in practically all nerve 
terminal-containing regions of the brain examined. A com- 
parison of the distribution of the two antigens in two brain 
regions is shown in Fig.  1. 
Fig. 1, a  and b shows a pair of sections of the cerebellar 
cortex.  In this brain region both p38  and synapsin I  im- 
munoreactivities occur  in  the  form of small  dots  in  the 
molecular layer and of large irregular islands in the granule 
cell layer.  This is precisely the  distribution expected for 
nerve terminals (8).  Individual dots in the molecular layer 
correspond to single axon terminals, primarily parallel fiber 
terminals, by far the predominant type of terminal in this 
layer. Islands of immunoreactivity in the granule cell layer 
represent mossy fiber terminals and satellite nerve terminals 
of the cerebellar glomeruli. 
Fig.  I, c and d shows a pair of sections of the CA3-CA4 
region of the hippocampus. In this hippocampal region, a 
predominant population of very small fluorescent dots is 
seen in the stratum oriens and in the top portions of the stra- 
tum radiatum. These dots represent primarily small termi- 
nals around distal apical dendrites (in the stratum radiatum) 
and around basal dendrites (in the stratum oriens) of pyrami- 
dal cells. A population of large, brightly fluorescent dots, 
most of which are located in the bottom part of the stratum 
radiatum, corresponds to the very large mossy fiber termi- 
nals which establish multiple synaptic contacts with spines 
of proximal portions of pyramidal cell apical dendrites (8). 
The similarity of the p38 and synapsin I staining patterns 
described above for two brain regions was found in all axon 
terminal-containing regions of the central nervous system 
studied with the exception of the retina (see Discussion). 
Similar results were obtained in the peripheral nervous sys- 
tem, where the presence of p38 was demonstrated by im- 
munofluorescence in autonomic ganglia and in all innervated 
tissues examined. These included the striated muscle, the vas 
deferens, various regions of the gastrointestinal system, and 
a variety of exocrine and endocrine glands (see for example 
Fig. 6 c and not shown). The distribution of p38 was consis- 
tent with its presence at all SSV-containing  regions, and, in 
all cases, the p38 staining pattern on neuronal processes was 
very similar to that of synapsin I. 
A  difference in the distribution of the two antigens  was 
only observed in the perikaryal  region of neurons, where 
both  antigens  were present at low concentration  (Fig.  2). 
p38-IgGs  stained elongated,  irregularly  shaped,  particles, 
which formed a network around the nucleus. The morpho- 
logical  distribution  of these  particles  inside  the  cell  cor- 
responded to that of the Golgi complex (11). Such a network 
of particles was consistently observed in all neurons, even 
though the intensity of the staining varied from one cell type 
to another.  Examples of such perikaryal  networks can be 
seen in the two neurons shown in Fig. 2, a and b. In contrast, 
syn I-IgGs produced a faint diffuse staining  throughout  the 
cytoplasm of perikarya  and major dendrites (Fig.  2  c). 
None of the  staining  patterns  described was seen when 
control  IgGs  were substituted  for p38-  or synI-IgGs  (not 
shown). 
Consistent with the morphological results,  the ratio  be- 
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identical to the value (3.8 ~tg/mg total protein) for synapsin 
I reported earlier (15). Since p38 seems to be a dimer cross- 
linked with S-S bonds in its native form (37; our unpublished 
observations) yielding a native molecular mass of 76,000 D, 
the stoichiometric ratio of synapsin I to p38  is close to 1. 
Figure 2. Comparison of the distribution  of p38 (a and b) and syn- 
apsin I (c) immunoreactivities  in the perikaryal regions of neurons. 
1-txm thick plastic sections stained by immunofluorescence.  (a and 
b) The figures show the perikarya of two brain stem neurons out- 
lined by immunoreactive  terminals of axosomatic synapses. Inside 
the cytoplasm a network of faintly labeled perinuclear  particles (ar- 
rows) can be seen (the nucleus of the neuron shown in a is out of 
the plane of section). These have the distribution expected for ele- 
ments of the Golgi complex.  (c) Neuron of the deep  cerebellar 
nuclei. A very weak diffuse fluorescence  is visible throughout the 
cytoplasm but not in the nucleus. Bars, 40 p.m. 
tween p38 content and synapsin I content, as assessed by a 
quantitative  dot-immunobinding assay, was found to be quite 
constant in all brain regions examined (Fig. 3). The absolute 
amount of p38  in brain  tissue was determined using puri- 
fied p38 as a standard.  In cerebral cortex homogenate,  the 
SubceUular Localization of  p38 in Neurons by 
Immunogold Electron Microscopy  Cytochemistry 
To study the distribution of p38 in brain tissue at the electron 
microscopic level by immunogold, we used a technique that 
involves  labeling  of subcellular  particles  embedded  in  an 
agarose matrix (10). As in a previous study of synapsin I (32), 
we used the bovine hypothalamus  for these experiments. The 
hypothalamus  was  chosen  because  of its  high  content  of 
LDCVs,  the bovine  species because of the relatively  large 
size  of the  hypothalarnus.  Embedding  total  homogenates 
(32), rather than synaptosomal fractions (10),  in agarose al- 
lowed us  to investigate  the distribution  of p38  not only  in 
nerve endings but also in other subcellular organelles. When 
the homogenization of the tissue was performed under gentle 
conditions,  undisrupted  cell  fragments  and clusters of or- 
ganelles still arranged in what appeared to be the original in 
situ configuration could be observed in the final embedded 
preparation. 
Both lytic (hypotonic) and nonlytic (isotonic) fixation con- 
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Figure 3.  Relative amounts of p38 and 
synapsin I in various  regions of the rat 
brain as quantitated  by a dot-immuno- 
binding assay. For comparison, the val- 
ues obtained  per mg of cortex protein 
were defined as 100. The figure shows a 
representative  experiment. 
Figure 1. Comparison of the localization of p38 (a and c) and synapsin I (b and d) immunoreactivities  in the rat cerebellar cortex (a and 
b) and in the CA3-CA4 region of the rat hippocampus  (c and d).  1-p.m thick plastic sections (a few micrometers  apart)  stained by im- 
munofluorescence  were used for comparison. In all the micrographs,  fluorescent dots, which vary in size, represent individual  nerve termi- 
nals. (a and b) In both fields, tightly apposed immunoreactive  dots visible in the molecular layer (ML) represent individual nerve endings. 
Their bright fluorescence  outlines the negative image of dendritic branches and cell somata.  A thick arrow points at the unstained main 
dendritic trunk of the same Purkinje cell. The surfaces of Purkinje cell perikarya are discontinuously  outlined by immunofluorescent  dots 
representing nerve endings of axosomatic synapses (arrowheads).  Large dots in the granule cell layer (GL) represent the large cerebellar 
mossy fiber terminals (thin arrows) which terminate in the glomeruli. V, blood vessel.  (c and d) Large dots concentrated  in the bottom 
part of the stratum radiatum (SR), just above the layer of pyramidal cell perikarya in the stratum pyramidale (SP), represent the large hip- 
pocampal mossy fiber terminals making synaptic contacts primarily with the proximal portion of the apical dendrites of pyramidal cells. 
The mossy fiber terminals seen in the stratum pyramidale in d, but not in c, are attributable to the slightly different regions of the stratum 
pyramidale shown in the two fields. Thin arrows point to the unstained distal segments of pyramidal cell apical dendrites which are outlined 
by very fine immunoreactive endings.  SO,  stratum oriens. Bar, 40 p.m. 
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organdies of agarose-embedded lysed nerve endings of bovine 
hypothalami.  Immunogold labeling of homogenates fixed under 
hypotonic conditions, a  and b show that,  in addition to labeling 
SSVs, immunogold also labels, to a variable extent, larger vacuoles 
(asterisks).  Gold  particles  on these  vesicles  are located  at  the 
cytoplasmic surface. Other organelles of the ending, including the 
ditions were used. The lytic fixation was aimed at opening 
all nerve endings resealed after the homogenization, which 
represented more than 50% of the nerve endings in a total 
homogenate, and which would otherwise have been inacces- 
sible to immunological probes (10). 
The bulk of p38 immunoreactivity was found to be local- 
ized in nerve endings (Figs. 4 and 5) and all lysed nerve end- 
ings were heavily labeled. Inside nerve endings, the large 
majority of gold particles was associated with the cytoplas- 
mic  surface of SSVs.  Labeling of individual vesicles was 
variable, possibly as a result of variable accessibility (due to 
the presence of nearby organelles or of cytoplasmic matrix). 
Some vesicles were heavily labeled and as many as 30 gold 
particles were counted around individual SSVs. In contrast 
to the heavy labeling of  SSVs, LDCVs were consistently unla- 
beled (Fig. 4). Whenever clusters of  gold particles were visi- 
ble in proximity to the  surface of LDCVs,  they couM be 
ascribed to nearby SSVs. Lack of labeling of LDCVs was so 
striking  that  a  morphometric  analysis  of the  differential 
labeling of SSVs and LDCVs (as had been carried out for syn- 
apsin I  [32]) did not appear to be necessary. 
Sparse to intense immunolabeling was also observed on 
the cytoplasmic surface of some vesicle profiles larger than 
SSVs and without a dense core (Figs. 4, b and c and 5, a and 
b). These might represent intermediate stages in the process 
of re-formation of SSVs after endocytosis (19).  Most large 
vesicular profiles of  nerve endings, however, were unlabeled. 
Few coated vesicles were seen in our preparations (10, 20). 
Those that were seen were usually unlabeled (Fig. 5  a,  in- 
set). This is in contrast to the previously reported observa- 
tion that p38 is enriched in brain coated vesicles (36, 49), 
but is  in  agreement with a  previous morphological study 
(47). Lack of labeling on coated vesicles might reflect poor 
accessibility of the  vesicle membrane to immunoreagents 
due to the presence of  the coat. The plasmalemma, both syn- 
aptic  and  extrasynaptic,  was  consistently unlabeled,  sug- 
gesting the existence of mechanisms that prevent intermix- 
ing  of membrane  components  upon  SSV  exocytosis (cf. 
reference 46). 
Apart from vesicles in nerve endings,  only a  few other 
smooth-surfaced vesicular profiles present in the homoge- 
nate were decorated by immunogold in the agarose-embed- 
ded preparations (not shown). Most of these particles were 
small  vesicles.  All  other  subcellular  particles,  including 
large plasmalemma sheaths and rough endoplasmic reticu- 
lum membranes, were not labeled above background. None 
of the labeling described with p38-IgGs was seen in prepara- 
tions processed with control-IgGs (Fig. 5 c). 
largest vacuolar profiles such as that marked by v in a, and the plas- 
malemma, are unlabeled. The inset of a  shows a detail of lysed 
nerve ending which includes a coated vesicle (cv). The latter is un- 
labeled. (c) Nerve ending from a preparation reacted with control- 
IgGs rather than p38-IgGs. No relevant labeling is visible. Bars: (a) 
100 nm; (b and c) 150 nm. 
Figure 4. Gallery of electron micrographs showing details of lysed nerve endings and illustrating the selective association of  p38 with SSVs. 
Immunogold labeling of agarose-embedded bovine hypothalamic homogenates fixed in hypotonic (a and b) or isotonic (c) conditions. Im- 
munogold particles are selectively localized and concentrated on the cytoplasmic surface of SSVs (pairs of small arrows). Besides SSVs, 
the only labeled organelles are some vacuoles which are slightly larger than the average SSVs and have a clear content (asterisks).  LDCVs 
(large arrows) and all other organelles are unlabeled, m, mitochondrion. Bars,  100 nm. 
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secretogranin  II (b and  d)  immunoreactivity in the  rat  adrenal 
medulla (a and b; 1-~tm  thick frozen sections) and anterior pituitary 
(c and d; 1-1~m  thick plastic sections).  In a and c a faint, finely punc- 
tate,  fluorescence can be seen throughout the cytoplasm.  A more 
intense accumulation of immunoreactivity is seen in proximity of 
nuclei (arrows), at the site of  the Golgi complex, which has a differ- 
ent light microscopic morphology in chromaffin cells and in pitui- 
cytes. In b and d, which show similar  regions of the same glands, 
an evenly distributed  population of fluorescent  puncta of roughly 
equal size and staining intensity occupies the cell cytoplasm. Such 
puncta represent  secretory granules.  SII,  secretogranin  II. Bars, 
10 ~tm. 
Figure 7. Localization of p38 by immunofluorescence in frozen sec- 
tions of the rat pancreas.  (a) Low power view of a pancreatic islet. 
P38 immunoreactivity is detectable in all endocrine cells of  the islet 
but is more concentrated in cells localized at its periphery. This may 
reflect  a difference  in concentration of p38 in Cells that produce 
different types of pancreatic hormones. The exocrine pancreas (E) 
is unstained.  (b) High power view of the field enclosed by the rec- 
tangle in a. The figure shows that two patterns  of immunoreactivity 
coexist  in  individual  endocrine cells.  One consists  of a  diffuse 
cytoplasmic stain, the other of  a more intense particulate  stain local- 
ized in a paranuclear region (short arrows). Long arrows point at 
immunoreactive nerve terminals.  Bars: (a) 35 Ixm; (b)  15 ~tm. 
Distribution  of  p38 in Non-neuronal  Tissues 
In a survey of several non-neuronal tissues by light micros- 
copy immunocytochemistry, p38 was found in a  variety of 
endocrine cells.  Under similar conditions of immunostain- 
ing,  synapsin  I  immunoreactivity  was  consistently  found 
only  in  nerve  terminal-containing  regions  (e.g.,  Fig.  6; 
unpublished  observations).  Non-neuronal  cells  highly  im- 
munoreactive for p38 included chromaflin cells of the adre- 
nal medulla (Fig. 6 a; see also Fig. 8 a), endocrine cells of 
the stomach (Fig. 6 c) and of the pancreas (Fig. 7), cells of 
the anterior pituitary (Fig.  8 c), and type C  cells of the thy- 
roid  (not  shown).  The  identity  of the  sparse  p38-positive 
cells in the stomach and thyroid as endocrine cells was estab- 
lished by labeling adjacent sections with antibodies directed 
against  secretogranin  II,  a  secretory  protein  previously 
shown to be a marker for a variety of cells of the neuroendo- 
crine system (39, 40). The intensity of immunostaining was 
not the same in all p38-positive cells  (see for example the 
more intense immunofluorescence of the peripheral cells in 
the islets of Langerhans; Fig. 7 a), indicating differences in 
the concentrations of p38 in different subpopulations of en- 
docrine cells.  With the possible exception of parotid acinar 
cells, in which a low level of immunoreactivity was discerni- 
Figure  6.  Comparison of the distribution  of p38 (a and c) and synapsin I (b and d) immunoreactivity in the rat adrenal  gland (a and b) 
and the mucosa of the rat stomach (c and d). Frozen sections stained by immunofluorescence.  (a and b) Bright fluorescent puncta (arrows) 
scattered  among chromaflin cells of the adrenal medulla are visible  in sections  stained  either for p38 or for synapsin  I. They represent 
axon terminals  innervating chromaffin ceils. No axon terminals are visible in the adrenal  cortex, which is not innervated.  Chromaffin ceils 
are p38-positive but synapsin 1-negative. M, medulla; C, cortex. (c and d) Varicose fluorescent fibers visible in both fields (arrows) represent 
"en passant"  varicose terminals innervating  the gastric glands.  The sparse  ceils  scattered  among the glands,  which are positive  for p38 
but negative  for synapsin I, represent  endocrine ceils (e) of the stomach mucosa. Exocrine cells of the gastric gland are immunoreactive 
neither for p38 nor for synapsin I. The low-level fluorescence visible in parietal cells (p) in both fields represents  nonspecific fluorescence. 
v, blood vessel  surrounded by immunoreactive "en passant"  varicose terminals.  Bars,  40 ~tm. 
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sues, and relationship between neuronal and non-neuronal p38 as 
revealed by deglycosilation of the molecule. (Top) Immunoblot of 
total homogenates of rat and bovine tissues and of two cell lines. 
The protein samples were separated on a 9-13  % linear gradient 
SDS polyacrylamide gel and transferred to a nitrocellulose mem- 
brane. The blot was labeled with p38-IgGs and the immunoreactive 
bands visualized using ~25I-protein A. Lane a, Purified rat brain 
p38 (12.5 ng of protein): lanes b-h, homogenates (10 gg of protein 
per lane) of:  (b) rat brain cortex;  (c) rat anterior pituitary;  (d) 
GI-h-ceUs; (e) PC12 cells; (f) rat brain cortex; (g) bovine adrenal 
medulla; (h) bovine adrenal chromatfin cells. The band labeled by 
an arrow corresponds to the dimeric form of  p38 (see Materials and 
Methods). Note that p38 immunoreactivity in non-neuronal tissues 
has a slightly lower electrophoretic mobility than brain p38. (Bot- 
tom) Deglycosylation of p38 purified from rat brain (lanes A) and 
from PC12 cells (lanes B), showing that the protein core of  p38 has 
the same electrophoretic mobility. Deglycosylation was carried out 
by trifluoromethanesulfonic acid. The reaction was carried out for 
the time indicated at the top of the lanes. The samples were sepa- 
rated  on  a  9-13% linear  gradient  SDS  polyacrylamide  gel  (3 
gg/lane) and transferred to a nitrocellulose membrane. The blot was 
labeled with p38-IgGs and the immunoreactive band was visualized 
using immunoperoxidase. The figure shows the p38-containing re- 
gion of the gel. The arrow points to the position of the deglycosy- 
lated form of p38. 
ble, no cells other than those of the neuroendocrine system 
were found to be immunoreactive. 
The presence of p38 in a variety of tissues was also inves- 
tigated by blot analysis of total homogenate proteins. Outside 
the brain significant amounts of p38 immunoreactivity were 
detected in tissues composed primarily of neuroendocrine 
cells, namely the adrenal medulla and the anterior pituitary 
(Fig. 9, top). p38 immunoreactivity was also highly concen- 
trated in cell lines derived from these two tissues, namely 
PC12  and GI-I4 cells (Fig.  9,  top).  Liver, skeletal muscle, 
several exocrine glands (pancreas, submaxillary, and lacri- 
mal glands), lung, kidney, and testes were either found to be 
negative or to contain only faint immunoreactivity (attribut- 
able either to their innervation or to the presence of a small 
proportion of neuroendocrine cells). A significant amount of 
p38-1ike immunoreactivity could be detected in the parotid 
gland with the serum antibody (not shown); however, none 
of the four monoclonal antibodies tested cross-reacted with 
this band. In all other tissues, identical results were obtained 
with serum and monoclonal antibodies. 
As can be seen from Fig. 9 (top), the protein band cross- 
reacting with the p38-IgGs in endocrine tissues exhibited a 
slightly higher apparent molecular weight than did brain 
p38. To establish whether this difference was due to a differ- 
ence of the protein core or of the sugar part of the molecule, 
p38 fractions isolated from rat brain and from PC  12 cells 
were deglycosylated in parallel incubations using trifluoro- 
methanesulfonic acid.  The results of one such experiment 
are shown in Fig. 9 (bottom). During the course of the reac- 
tion, in both brain and PC 12 samples, an identical protein 
band of ,,o  34,000 D appeared (arrow), which was apparently 
generated from the higher molecular weight form. The reac- 
tion seemed to be complete after 10 h of incubation since ex- 
tended  treatment  did  not  further change  the  pattern  (not 
shown). 
SubceUular Localization of  p38 in Non-neuronal Cells 
Light Microscopy Immunocytochemistry.  High power ob- 
servation of tissue sections stained for p38 by immunofluo- 
rescence revealed that the immunoreactivity for this protein 
was unevenly distributed within endocrine cells. A moderate 
to high level of immunoreactivity was visible throughout the 
cytoplasm (Figs. 7 b and 8, a and c). In addition, a more in- 
tense immunoreactivity was visible in the vicinity of the nu- 
cleus  (Fig.  7  b  and  8,  a  and  c).  The distribution of this 
paranuclear material varied in different types of endocrine 
cells and was reminiscent of the light microscopic appear- 
ance of the Golgi complex characteristic of that given cell 
type (for example, reference 34, unpublished observations). 
Comparison of the  staining  patterns  obtained after im- 
munostaining for p38 and secretogranin H (used here as a 
marker for secretory granules) (39, 40) revealed a  striking 
difference in the distribution of the two proteins (Fig.  8). 
Secretogranin II immunoreactivity occurred in the form of 
very bright dots tightly packed throughout most of the cyto- 
plasm.  The texture of this punctate staining appeared quite 
different from the texture of the p38 staining. 
Electron Microscopy Immunocytochemistry.  To further 
identify the precise subcellular localization of p38 in endo- 
crine cells, we studied the distribution of p38 immunoreac- 
tivity in two cell types, the pituicytes of the rat anterior pitu- 
itary and the chromaflin cells of the bovine adrenal medulla, 
by two different and complementary immunogold electron 
microscopy techniques. 
(a) Adrenal Medulla: In chromaliin cells of the adrenal 
gland, the distribution of  p38 was studied by the same proce- 
dure used to determine the subcellular localization of p38 in 
the brain (see above), i.e., by immunolabeling total homoge- 
nates embedded in agarose. Bovine adrenal medullae were 
The Journal  of  Cell  Biology,  Volume 103,  1986  2520 Figure 10. Agarose-embedded  subcellular particles of bovine adrenal medulla homogenates labeled by immunogold for p38. The figure 
shows a gallery of  various types of  membrane profiles which are p38 positive (arrows). These profiles are either small round or oval vesicles 
(a and c),  small tubules  (b and d), or larger, highly infolded vacuoles (e and f). Membranes  of secretory granules  (G), mitochondria 
(M), and other organelles are unlabeled. The different staining intensity of the core of secretory granules in the various fields is the result 
of different times of counterstaining.  Bars,  100 txm. 
used  for  these  experiments.  In  these  preparations,  p38- 
immunogold selectively labeled a pleiomorphic population 
of smooth-surfaced membranes. These were predominantly 
round or oval vesicles with a dimension in the same range 
as that of small synaptic vesicles of neurons (Fig.  10). Occa- 
sionally, small tubular profiles (Fig.  I0, b and d) and larger 
structures  with  highly  infolded  profiles (Fig.  10,  e  and f) 
were also seen. Most of the labeled vesicular surfaces were 
randomly interspersed with other organelles, but clusters of 
them were consistently seen in proximity to centrioles and 
to remnants of the Golgi complex (piles of a  few flattened 
cisternae) (not shown). 
In general the labeling density on all p38-positive mem- 
branes was high.  Only rare,  scattered, gold particles were 
seen on secretory granules.  Immunogold was virtually ab- 
sent from all other organelles. None of the specific label de- 
scribed was observed in preparations reacted with control- 
IgGs instead of p38-IgGs. 
(b) Anterior Pituitary: In the anterior pituitary the subcel- 
lular localization of p38 was studied by surface labeling of 
Navone et al. Protein p38 in Neurons and Neuroendocrine  Cells  2521 Figure 11. P38 immunoreactivity in the rat anterior pituitary as revealed by immunogold labeling of ultrathin frozen sections. (a) The great 
majority of gold particles appear to be associated with small vesicular profiles with clear content (arrows).  These are interspersed among 
secretory granules (G), sometimes in close proximity to them (GO. (b) p38-positive vesicles (arrows) are visible in the proximity of the 
plasmalemma. Only scattered particles are visible on most regions of the plasmalemma itself. The inset of b  shows two plasmalemma 
invaginations, one of which is labeled by several gold particles. Bars,  150 Ixm. 
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plemented results obtained with the adrenal medulla because 
they allowed one not only to establish the identity of p38- 
positive organelles by another technique, but also to deter- 
mine their distribution in the context of intact cells. Some 
results are illustrated in Figs.  11 and 12 a. 
By far the  majority of immunogold particles  were as- 
sociated with smooth-surfaced small vesicular profiles scat- 
tered among secretory granules and concentrated in close 
proximity to the Golgi complex. These vesicular profiles had 
variable shapes ranging from small round or oval vesicles 
to irregularly shaped vacuoles and short tubules.  Not all 
smooth-surfaced vesicular profiles appeared to be labeled 
and, even at the para-Golgi region, clusters of labeled vesi- 
cles were interspersed with clusters of unlabeled vesicles. 
Very few gold particles  were  seen on membranes of the 
rough endoplasmic reticulum (Fig. 12 a), on membranes of 
the major Golgi stacks (Fig.  12 a, inset), or on profiles of 
secretory granule membranes (Figs. n  and 12 a). Only scat- 
tered gold particles were visible on the plasmalemma (Fig. 
11 b), but a high density of particles was occasionally seen 
at plasmalemma invaginations (Fig. 11 b, inset). Mitochon- 
dria were consistently unlabeled. 
The specificity of the labeling was assessed by two con- 
trols. Sections adjacent to those immunolabeled for p38 were 
immunolabeled with either control-IgGs or with IgGs di- 
rected against secretogranin II. The labeling described above 
was totally absent in sections reacted with control-IgGs. The 
distribution of secretogranln 1I immunoreactivity was com- 
pletely different from the distribution of p38 immunoreac- 
tivity. The labeling pattern for this antigen is illustrated in 
Fig.  12 b, which shows a cytoplasmic region including the 
Golgi complex. Practically all immunogold particles were 
concentrated on the core of secretory granules. 
Discussion 
p38 in Neurons 
Two previous studies demonstrated the presence of a major 
synaptic vesicle protein p38 (also referred to as synaptophy- 
sin [47l) in terminals of several regions of  the nervous system 
(22, 47). In this study we show both by immunohistochemis- 
try and by a quantitative immunoassay that in nearly all brain 
regions p38 has a distribution very similar to that of synapsin 
I (9). Since synapsin I is known to be present in virtually all 
nerve endings (9,  10), our results suggest that p38 also has 
a ubiquitous distribution in nerve endings. The stoichiomet- 
ric ratio of the two proteins is close to 1. A discrepancy be- 
tween the nerve terminal distribution of p38 and synapsin I 
was noted only at highly specialized synaptic regions, such 
as the inner and outer plexiform layers of the retina (47; our 
unpublished  results)  and  the  vestibular  neuroepithelium 
(Favre, D., D. Corey, G. Di Gioia, and E De Camilli, unpub- 
lished observations).  A  separate study of such specialized 
regions of the nervous system is in progress to determine 
whether the observed discrepancy is due to a lack of synapsin 
I, but not of  p38, from ribbon synapses (see also reference 8). 
Immunogold electron microscopy indicated that, at least 
in the hypothalamic nerve endings examined in this study, 
p38,  like synapsin I (32),  is localized on SSVs but not on 
LCDVs. Work in progress in our laboratories suggests that 
such a selective association of p38 with SSVs is general in 
the nervous system. By both immunocytochemistry  and sub- 
cellular  fractionation we  found that,  in  terminals  of the 
posterior pituitary, p38, like synapsin I (32), is selectively as- 
sociated with 40-60-nm  diam vesicles but not with neu- 
rosecretory granules (unpublished results). The function of 
40-60-nm diam vesicles in the posterior pituitary is still un- 
known, but they resemble in many respects SSVs of the brain 
(3). Further evidence for a selective association between p38 
and SSVs was provided by comparative immunofluorescence 
of adjacent sections of various brain regions using antibodies 
directed against p38,  synapsin I and secretogranin II (40). 
Secretogranin II is co-stored in secretory organelles with 
peptide neurotransmitters and can therefore be used as a 
marker for LDCVs. p38 and synapsin I staining patterns were 
always coincident,  but  at  many  sites  puncta  positive  for 
secretogranin II and negative for both synapsin I and p38 
were observed (Navone,  F., G. Di Gioia, A. Zanini, and P. 
De Camilli, unpublished observations). These puncta proba- 
bly represent individual LDCVs. 
Our results indicate that the membranes of the two sub- 
populations of secretory organelles of nerve endings, SSVs 
and LDCVs, have distinct compositions and that at least one 
extrinsic membrane protein (synapsin I) and one intrinsic 
membrane protein (p38) are shared by virtually all SSVs ir- 
respective of their neurotransmitter content. 
The moderate perinuclear staining produced by p38-IgGs 
suggests that a minor pool of neuronal p38  is concentrated 
in the area of the Golgi complex, p38 in the Golgi complex 
might represent either newly synthesized  p38 or p38 recycled 
from nerve terminals (17). In contrast to this perikaryal dis- 
tribution of  p38, the low level of synapsin I immunoreactivity 
visible in perikarya has a diffuse distribution.  2 This obser- 
vation suggests that binding of synapsin I (which is known 
to be synthesized on free ribosomes [13]) to p38-containing 
membranes takes place distally to the Golgi complex. So far 
we have no precise indication as to the site at which synapsin 
I becomes associated with p38-containing membranes. 
p38 in Endocrine Cells 
In contrast to synapsin I, which is present only in neurons, 
p38 is also present in a variety of endocrine cells specialized 
for regulated secretion of peptides via secretory granules, 
i.e., via the "established" pathway for regulated secretion (23, 
31). This distribution of p38 suggests that it might be a com- 
2. Goldenring et al. (16) have recently claimed that the localization of synap- 
sin I primarily in nerve terminals is artifactual and that, if detergents are 
omitted from staining solutions, synapsin I immunostaining becomes very 
prominent in perikarya and dendrites. However, evidence indicating a pre- 
dominant localization of synapsin I in nerve terminals is compelling (pres- 
ent study and references 8, 10, 29, and 32). This evidence is based on a vari- 
ety of light microscopy techniques, including surface staining of ultrathin 
frozen sections, a procedure which does not involve use of detergents (12). 
The results of Goldenring et al., obtained by immunoperoxidase staining of 
nonpermeabilized  thick vibratome sections, can be explained by the fact that 
antibodies penetrate  much  more  readily  into  large  structures,  such  as 
perikarya and major dendrites, which are split open by the knife cut, than 
they do into small cellular compartments, such as nerve endings, most of 
which are separated from the surface of section by a number of intervening 
membranes. Under the experimental conditions used by Goldenring et al., 
the ratio of perikaryal and dendritic staining to nerve ending staining can 
appear much higher because saturating levels of peroxide reaction product 
are reached in perikarya and dendrites before substantial staining is achieved 
in nerve endings. 
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to being specialized for the secretion of regulatory peptides, 
share a variety of other properties including a common ori- 
gin from the neural crest (35).  Endocrine cells that secrete 
peptide hormones via a  regulated pathway and were found 
to be p38-negative include cardiac atrial cells (which secrete 
natriuretic  peptides  [7])  and  some  endocrine  cells  inter- 
spersed among epithelial cells in the surface epithelium of 
the duodenal mucosa. Cardiac atrial cells, however, do not 
originate from the neural crest, and it is controversial as to 
whether endocrine epithelial cells of the duodenal mucosa 
are derived from the neural crest (35). It should also be men- 
tioned that the origin of the endocrine cells of the pancreas 
(which are p38-positive) from the neural crest has been ques- 
tioned. 
Our results differ somewhat from those reported for synap- 
tophysin by Wiedenmann et al.  (47) and Rehm et al.  (37). 
Those authors found a more restricted distribution of synap- 
tophysin,  since they could not detect  it in endocrine cells 
other than chromaffin cells of the adrenal. 3 Moreover, they 
found synaptophysin to be restricted in its phylogenetic dis- 
tribution to mammals, whereas we have found p38 immuno- 
reactivity to  be present  in  all  five vertebrate classes  and 
several invertebrate species (unpublished results). These dis- 
crepancies might be due to a more limited epitope specificity 
of the antibodies used by those authors, and suggest that het- 
erogeneous forms of p38 might exist in different tissues and 
species. In fact, the brain and endocrine forms of p38 differ 
in their sugar portions, because the observed heterogeneity 
of their electrophoretic mobilities disappeared after chemi- 
cal deglycosylation. The shift in apparent molecular weight 
(from 38,000 to '~34,000 D) after deglycosylation is consis- 
tent with the report of Rehm et al.  (37), who found a com- 
parable reduction of the molecular weight of synaptophysin 
in PCI2 cells after incubation with tunicamycin. 
p38 in endocrine cells was not localized on secretory gran- 
ules.  At the light microscopic level p38  immunoreactivity 
did not colocalize with secretory granules as demonstrated 
by the different fluorescence patterns obtained after staining 
for p38 or for secretogranin II. This was further confirmed 
by  results  of  electron  microscopy  immunocytochemistry 
which, in addition, allowed the determination of the precise 
intracellular localization of p38. p38 in endocrine cells was 
found to be selectively localized on a population of smooth- 
surfaced small vesicles and vacuoles with clear content, scat- 
tered among the granules, and particularly concentrated in 
the area of the Golgi complex. These results agree with the 
finding of Wiedenmann and Franke that adrenal medulla syn- 
3. After the completion of this manuscript, a study appeared reporting the 
occurrence of synaptophysin  in the islets of Langerhans and in a variety  of 
human neoplasms originating from neuroendocrine cells but not in any 
other type of normal neuroendocrine cells (48). 
aptophysin does not co-purify with secretory granules upon 
subceUular fractionation (47). Those authors suggested that 
adrenal synaptophysin might be localized on a distinct,  yet 
unidentified, type of organelle. In the present study, we have 
characterized  the  p38-positive organelles  and  shown  that 
they  are  not  specific  to  chromaffin  cells  of the  adrenal 
medulla. 
Possible Relationships between Secretory OrganeUes of 
Nerve Endings and OrganeUes of Endocrine Cells 
The selective localization of p38 on SSVs in nerve endings 
further supports the idea that SSVs and LDCVs are secretory 
organelles of two distinct, and differentially regulated, secre- 
tory pathways. Furthermore, the presence of p38 on small 
vesicles in a variety of endocrine cells suggests that SSVs, 
which are regarded as neuron-specific organelles, are some- 
how related to an as yet uncharacterized endomembrane sys- 
tem present in a variety of endocrine cells, but distinct from 
the typical secretory granules.  The finding that p38 is not 
present either on neuronal LDCVs or on endocrine secretory 
granules is in line with the concept that these two organelles 
are structurally and functionally related (32). 
The physiological role of p38-positive vesicles in endo- 
crine cells remains to be defined. Their accumulation in the 
area of the Golgi complex and the presence of p38-positive 
plasmalemmal invaginations suggest that p38-positive vesi- 
cles may be part of a  system that functionally connects the 
area of the Golgi complex with the cell surface. The frequent 
association observed between p38-positive vesicles and cen- 
trioles further supports this interpretation,  since centrioles 
appear to coordinate, via the microtubular network, the traf- 
fic in and out of the Golgi complex area (45).  It should be 
noted that SSVs also provide a functional continuity between 
the Golgi complex area and the cell surface in nerve cells. 
On the other hand, p38-positive vesicles of endocrine cells 
clearly differ from neuronal SSVs.  They are heterogeneous 
in size and shape, and synapsin I is not present on their sur- 
face. Furthermore, in neurons by far the largest pool of p38- 
positive vesicles is concentrated in close proximity to exo- 
cytotic sites, while only a small pool of p38 is present in the 
Golgi  complex area.  In contrast,  in endocrine cells p38- 
positive vesicles are highly concentrated in proximity to the 
Golgi complex and do not appear to accumulate and cluster 
under the plasmalemma. 
It is possible that neuronal SSVs and p38-positive vesicles 
of endocrine cells are cell type-specific variants of the same 
organelle. Synapsin I, a protein thought to act as a link be- 
tween SSVs and the cytoskeleton (9, 32), might be involved 
in the adaptation of such organelles for neuronal function. 
It will be important to determine how many proteins of SSVs, 
in addition to p38, are shared by the endocrine vesicles. Two 
other intrinsic membrane proteins of SSVs have previously 
Figure 12. Ultra-thin frozen sections of rat anterior pituitary showing the Golgi area labeled by immunogold for p38 (a) and secretogranin 
II (b). (a) A high density of gold particles is visible in the area of the Golgi complex (GC). The thickness of the section does not allow 
precise identification of the individual vesicles with which the label is associated, but clearly gold particles are concentrated on regions 
rich in small vesicular profiles with clear content. The inset shows that major Golgi stacks are unlabeled.  Only a low labeling density 
is visible on the rough endoplasmic reticulum (ER). G, secretory granule. (b) Gold particles are localized on the core of secretory granules 
(G). Clusters of gold particles not obviously localized on cores of secretory granules (arrows) can be explained by a poor preservation 
of the granule  core in these ultrathin frozen sections. Some granules are unlabeled (GI), consistent with a previous report of a heter- 
ogenous distribution of secretogranin II in granules of single individual cells in the anterior pituitary (39). M, mitochondria;  GC, Golgi 
complex.  Bar, 150 nm. 
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crine cells (5,  30).  It was inferred by the authors  of such 
studies  that  these  proteins  were probably  common  to  all 
secretory vesicles of neurons and to secretory granules of en- 
docrine cells. In light of the present results, the possibility 
should be considered that in neurons as well as in endocrine 
cells  these  proteins  might be  selectively  localized on  the 
same vesicle subpopulations which are p38-positive and ab- 
sent from LDCVs and endocrine secretory granules. 
Rehm et al.  have  recently reported that p38  is a major 
Ca2+-binding protein (Ca  2÷ being bound at the cytoplasmic 
domain of the molecule) and have suggested that, because of 
this property, p38 might play an important physiological role 
in regulated exocytosis from neurons (37). This is an interest- 
ing  possibility,  but the  lack of p38  on peptide-containing 
secretory  granules  of neurons  and endocrine cells argues 
against a general role of p38 in all types of regulated exocyto- 
sis. Furthermore it remains to be demonstrated whether p38- 
positive vesicles in endocrine cells undergo a regulated inter- 
action with the plasmalemma. 
Whatever  the physiological function of p38-positive vesi- 
cles in endocrine cells might be, it may be assumed that some 
relation exists between such function and their function in 
neurons. Thus the study  of the function of such endocrine 
vesicles may  lead to the discovery of previously unknown 
functions of SSVs  (in addition to that of being involved in 
neurotransmitter  secretion)  and/or of previously unknown 
secretory properties of endocrine cells. 
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